- Home
- / PrimeCell Advanced Therapy
PrimeCell Advanced Therapy
Revenue
KČ23.5 M
FY, 2018
PrimeCell Advanced Therapy Summary
Company Summary
- Overview
- PrimeCell Advanced Therapy is a bio-med company. It focuses on discovering and clinical testing of biological drugs and medicinal technologies, which are changing genes and cell parameters to support the regeneration of human tissues and organs.
- Type
- Subsidiary
- Status
- Active
- Founded
- 2007
- HQ
- Prague, CZ | view all locations
- Website
- https://www.primecell.eu/
- Cybersecurity rating
Table of Contents
Key People
Serhiy Forostyak, Chief Scientific Officer
Michal Zahradnicek, Chairman of the Board
Ivo Kristen, Board Member
Operating MetricsView all
Projects (Research)
35
Jun, 2020
Patients Served per Year
5K
Jun, 2020
Labs, sq. m.
10K
Jun, 2020
LocationsView all
4 locations detected
Prague, Hlavní město Praha HQ
Czech Republic
Jáchymova 26/2
Ostrava, Moravskoslezský kraj
Czech Republic
Dr. Slabihoudka 6232/11
Jihomoravský kraj
Czech Republic
Palachovo nám. 726/2
Bratislava, Bratislavský kraj
Slovakia
Tematínska 3264/5
PrimeCell Advanced Therapy Financials
Summary Financials
- Revenue (FY, 2018)
- Kč23.5M
- Gross profit (FY, 2018)
- Kč8.7M
- Net income (FY, 2018)
- Kč12.4M
- Cash (FY, 2018)
- Kč328.0K
- EBIT (FY, 2018)
- Kč13.7M